Home
Home

Neurosearch

3 Pipeline Obesity Treatments You Should Watch

3 Pipeline Obesity Treatments You Should Watch
Motley Fool

Teva acquires Huntexil development programme rights from NeuroSearch

Teva acquires Huntexil development programme rights from NeuroSearch
Pharmabiz

Teva Pharma acquires rights to Huntexil for $26M

Teva Pharma acquires rights to Huntexil for $26M
Yahoo/AP

News

MermaiHD Madness: NeuroSearch's Statistically Significant Snafu
InVivo
»

News

GSK: Rare Diseases Now Big Business
WSJ Online
»

News

NeuroSearch announces drug discovery and drug development alliance with Janssen Pharmaceutica NV
Neurosearch Press Release
»

News

NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials
Seeking Alpha
»

News

Lilly to boost biotech stake in NeuroSearch deal
PharmaFocus
»

News

For Antidepressants, Maybe Three Targets Will Be Better than Two
WSJ Online
»